Summary

Switzerland has overcome the critical shortage of antibiotics and vaccines. The two emergency ordinances of the SERI will be repealed as of March 1, 2026, as the supply situation has stabilized and mandatory stockpiles have been rebuilt. However, supply problems in other pharmaceutical areas persist, caused by global production shifts and market dependencies.

Persons

Topics

  • Pharmaceutical supply in Switzerland
  • Antibiotic shortage
  • Vaccine availability
  • Mandatory stockpiles and emergency measures
  • Global supply chains

Clarus Lead

Switzerland is ending its emergency measures to secure antibiotic and vaccine supply. After years of shortage management, the two emergency ordinances of the SERI can be repealed as of March 1, 2026. This signals relief in two critical supply areas – but remains an exception in a fragmented pharmaceutical market.

Detailed Summary

The ordinance for the release of mandatory stockpiles for anti-infectives was issued on November 1, 2019 in response to severe shortages of intravenously administered antibiotics. In March 2023, it was expanded to all forms of administration, including oral medications. The second emergency ordinance for human vaccines followed on July 15, 2023. Both measures made it possible to use strategic mandatory stockpiles to bridge supply shortages.

In the meantime, the situation has normalized. The mandatory stockpiles have been almost completely rebuilt, and the severe shortage has been resolved. However, it cannot be ruled out that isolated shortages may occur again in the future. The repeal of the ordinances from March 2026 does not mean that the risk has been completely eliminated – but rather that the situation is stable enough to operate without emergency measures.

The overarching problem remains: supply problems persist in other pharmaceutical areas. The reporting office for vital human pharmaceuticals regularly documents dozens of products that are only partially or not available at all. The causes are structural: production shifts to low-wage countries, strong dependencies on a few Asian production sites, and the reduction of inventory levels along supply chains. In addition, the Swiss market is globally small and unprofitable for many manufacturers.

The reporting office of the Pharmaceuticals Division of the Economic Supply Services (ES) records pharmaceutical availability and coordinates mandatory stockpile procurement. Since summer 2025, monitoring has been digitalized and is gradually being developed into an early warning system.

Key Messages

  • Emergency ended: Antibiotic and vaccine shortages have been overcome; ordinances will be repealed
  • Structural problems remain: Other pharmaceutical areas suffer from chronic supply problems
  • Global dependencies: Production shifts and market concentration threaten Swiss supply security
  • Digital monitoring: New early warning system is to detect future shortages earlier

Critical Questions

  1. Evidence: What concrete data demonstrate the "stabilization"? How are availability rates measured and what thresholds justify the repeal?

  2. Data Quality: Are pharmaceutical availability reports complete? What proportion of Swiss pharmacies and hospitals feed data into the reporting office?

  3. Incentives: What economic incentives do manufacturers have to resupply the Swiss market? Has profitability increased or only emergency stockpile levels?

  4. Causality: Are the improvements the result of emergency ordinances or global normalization after the pandemic? How can the effect be isolated?

  5. Future Risks: What measures prevent shortages from recurring? Is the digital early warning system sufficient, or are structural changes needed?

  6. Early Warning System Implementation: By when will the system be fully operational? What response times are realistic if new shortages are detected?

Source List

Primary Source: Supply of Switzerland with Antibiotics and Vaccines has Stabilized – Federal Press Release, February 23, 2026 – https://www.news.admin.ch/de/newnsb/J5fHK2v9DVcWtr4E4dbsh

Verification Status: ✓ February 23, 2026

This text was created with the support of an AI model. Editorial responsibility: clarus.news | Fact-checking: February 23, 2026